NYSE - Delayed Quote • USD
Ingevity Corporation (NGVT)
At close: April 19 at 4:00 PM EDT
After hours: April 19 at 5:48 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 6 | 6 | 6 | 6 |
Avg. Estimate | 0.32 | 1.1 | 3.6 | 4.99 |
Low Estimate | 0.08 | 0.91 | 3.32 | 4.3 |
High Estimate | 0.88 | 1.28 | 3.95 | 6.65 |
Year Ago EPS | 1.09 | 1.41 | 3.94 | 3.6 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 5 | 5 | 6 | 6 |
Avg. Estimate | 318.96M | 419.32M | 1.46B | 1.55B |
Low Estimate | 309.1M | 409.7M | 1.43B | 1.5B |
High Estimate | 330.6M | 430.9M | 1.53B | 1.67B |
Year Ago Sales | 411.22M | 486.43M | 1.69B | 1.46B |
Sales Growth (year/est) | -22.40% | -13.80% | -13.60% | 6.10% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | 1.13 | 1.37 | 1.21 | -0.19 |
EPS Actual | 1.09 | 1.41 | 1.21 | 0.21 |
Difference | -0.04 | 0.04 | 0 | 0.4 |
Surprise % | -3.50% | 2.90% | 0.00% | 210.50% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0.32 | 1.1 | 3.6 | 4.99 |
7 Days Ago | 0.35 | 1.06 | 3.6 | 4.99 |
30 Days Ago | 0.32 | 0.98 | 3.61 | 4.75 |
60 Days Ago | 0.02 | 1.08 | 3.42 | 5.25 |
90 Days Ago | 0.02 | 1.08 | 3.42 | 5.25 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | 1 | 2 | 1 | 1 |
Up Last 30 Days | 2 | 3 | 1 | 3 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | NGVT | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -70.60% | -- | -- | 1.60% |
Next Qtr. | -22.00% | -- | -- | 10.50% |
Current Year | -8.60% | -- | -- | 5.20% |
Next Year | 38.60% | -- | -- | 13.30% |
Next 5 Years (per annum) | 6.20% | -- | -- | 11.22% |
Past 5 Years (per annum) | -7.08% | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
Earnings
Upgrades & Downgrades
Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 2/23/2024 |
Maintains | BMO Capital: Market Perform to Market Perform | 11/9/2023 |
Downgrade | Loop Capital: Buy to Hold | 10/3/2023 |
Downgrade | BMO Capital: Outperform to Market Perform | 8/7/2023 |
Upgrade | Loop Capital: Hold to Buy | 7/27/2023 |
Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 5/23/2023 |
Related Tickers
OEC Orion S.A.
24.09
+2.47%
ALB-PA Albemarle Corporation
51.48
-0.79%
KOP Koppers Holdings Inc.
53.28
+0.24%
SXT Sensient Technologies Corporation
69.14
+1.33%
KWR Quaker Chemical Corporation
190.49
+1.32%
SCL Stepan Company
84.17
+2.57%
MTX Minerals Technologies Inc.
71.61
+0.84%
IOSP Innospec Inc.
122.28
+1.21%
HWKN Hawkins, Inc.
74.63
-0.09%
NEU NewMarket Corporation
586.34
+0.51%